{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-21-000051","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2021-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.161227+00:00","generated_at":"2026-06-29T23:52:41.110491+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SI-BONE posts record Q2 revenue of $22.2M, gets exclusive Anthem coverage","bullets":["Record Q2 worldwide revenue $22.2M (+58% YoY); U.S. revenue $20.2M (+53%).","Exclusive coverage from Anthem (40M+ members) expands SI joint fusion access; also positive Centene coverage.","Gross margin 89%; guidance raised to 87-89%; FY2021 revenue guidance maintained $92-94M.","Net loss $14.0M ($0.42/sh) vs $12.5M ($0.44/sh) prior year; operating loss $13.0M.","Published 2-year clinical trial results for iFuse-3D Implant System, 95th peer-reviewed publication."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-21-000051","json":"https://secwatch.observer/filing/0001459839-21-000051.json","markdown":"https://secwatch.observer/filing/0001459839-21-000051.md","text":"https://secwatch.observer/filing/0001459839-21-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/0001459839-21-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983921000051/sibn-20210802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:52:41.110491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}